Showing results (41-50 of 53) with videos related to
Sort By:
Pageof 6
Parkinsonism & Related Disorders|May 5, 2016
Clinical and neuroradiological features of spinocerebellar ataxia 38 (SCA38)Barbara Borroni, Eleonora Di Gregorio, Laura Orsi, et al.Frontiers in Cellular Neuroscience|November 23, 2017
Motor Deficits and Cerebellar Atrophy in Elovl5 Knock Out MiceEriola Hoxha, Rebecca M C Gabriele, Ilaria Balbo, et al.Glia|June 17, 2021
Elovl5 is required for proper action potential conduction along peripheral myelinated fibersEriola Hoxha, Ilaria Balbo, Roberta Parolisi, et al.Plos One|August 11, 2011
The collagen chaperone HSP47 is a new interactor of APP that affects the levels of extracellular beta-amyloid peptidesFederico T Bianchi, Paola Camera, Ugo Ala, et al.Acta Neuropathologica Communications|May 29, 2026
ATM-kinase deficiency triggers early multi-compartment remodeling of the cerebellar microenvironmentFrancesca Montarolo, Luna Berrino, Anita Maria Rominto, et al.Parkinsonism & Related Disorders|March 14, 2019
Long-term efficacy of docosahexaenoic acid (DHA) for Spinocerebellar Ataxia 38 (SCA38) treatment: An open label extension studyMarta Manes, Antonella Alberici, Eleonora Di Gregorio, et al.Glia|May 8, 2018
Sox2 conditional mutation in mouse causes ataxic symptoms, cerebellar vermis hypoplasia, and postnatal defects of Bergmann gliaValentina Cerrato, Sara Mercurio, Ketty Leto, et al.Annals of Neurology|October 5, 2017
Docosahexaenoic acid is a beneficial replacement treatment for spinocerebellar ataxia 38Marta Manes, Antonella Alberici, Eleonora Di Gregorio, et al.Human Genetics|May 18, 2023
Spinocerebellar ataxia 38: structure-function analysis shows ELOVL5 G230V is proteotoxic, conformationally altered and a mutational hotspotEnza Ferrero, Eleonora Di Gregorio, Marta Ferrero, et al.Nature Genetics|March 9, 2010
Mutations in the mitochondrial protease gene AFG3L2 cause dominant hereditary ataxia SCA28Daniela Di Bella, Federico Lazzaro, Alfredo Brusco, et al.Pageof 6